• Home
  • News
  • Government
  • Business & Finance
  • Entertainment
  • Sports
  • Tech
  • Health
  • About Federal Character
  • Advertise With Us
Federal Character
No Result
View All Result
Federal Character
  • Home
  • News
  • Government
  • Business & Finance
  • Entertainment
  • Sports
  • Tech
  • Health
  • About Federal Character
  • Advertise With Us
No Result
View All Result
Federal Character
No Result
View All Result
Home News
WHO Scrambles to Contain New Mpox Outbreak in Congo with Swift Vaccine Rollout

WHO Scrambles to Contain New Mpox Outbreak in Congo with Swift Vaccine Rollout

Eriki Joan UgunushebyEriki Joan Ugunushe
2 years ago
in News
Reading Time: 2 mins read
A A
0
Facebook ShareWhatsapp ShareX Share

The World Health Organization (WHO) announced on Friday that mpox vaccines are finally on their way to the Democratic Republic of Congo. The vaccines are set to arrive in the next few days, aiming to combat a new strain of the virus that has been wreaking havoc in the region.

WHO Director-General Tedros Adhanom Ghebreyesus stated, “We hope to have the first delivery in the next few days, and then it will build up.” With a sense of urgency, the WHO is moving quickly to ensure these vaccines reach those in need. According to Tim Nguyen, a WHO official, approximately 230,000 mpox vaccine doses are immediately available for dispatch. These vaccines, generously donated by the European Commission and Danish manufacturer Bavarian Nordic, are ready to be shipped out.

It has relaxed its stringent rules, allowing its partners to purchase mpox vaccines even before they receive official approval from the United Nations health agency. This change aims to expedite the delivery of inoculations to Africa, where the virus is spreading rapidly. Currently, the WHO is reviewing emergency license applications for two vaccines from Bavarian Nordic and Japan’s KM Biologics. Tedros indicated that these approvals could be granted within the next two weeks.

Rosamund Lewis, the WHO’s technical lead for mpox, expressed hope that these vaccines, along with other measures, will soon bring the surge in cases under control. Meanwhile, an unnamed mpox diagnostic manufacturer has also shown interest in securing WHO’s emergency use listing for their testing kit, just a day after the process was opened.

The urgency of this response is highlighted by the WHO’s declaration of mpox as a global public health emergency earlier this month, following an outbreak in the Democratic Republic of Congo that has already spread to neighboring countries. So far, Congo has reported over 18,000 suspected mpox cases and 629 deaths this year, while more than 150 cases have also been confirmed in Burundi. The situation is dire, and the world is watching closely as efforts to contain this outbreak unfold.

Tags: Congofederal characterMpoxNewsRolloutvaccineWHOWHO Scrambles to Contain New Mpox Outbreak in Congo with Swift Vaccine Rollout
Share234SendTweet147
Eriki Joan Ugunushe

Eriki Joan Ugunushe

Eriki Joan Ugunushe is a dedicated news writer and an aspiring entertainment and media lawyer. Graduated from the University of Ibadan, she combines her legal acumen with a passion for writing to craft compelling news stories.Eriki's commitment to effective communication shines through her participation in the Jobberman soft skills training, where she honed her abilities to overcome communication barriers, embrace the email culture, and provide and receive constructive feedback. She has also nurtured her creativity skills, understanding how creativity fosters critical thinking—a valuable asset in both writing and law.

Related Stories

Federal Judge Orders Emergency Hearing Over Kennedy Center Closure

Kennedy Center to Close as Court Blocks Trump Name on Building

bySomto Nwanolue
0

The Kennedy Center board has voted to close the performing arts centre for two years, just as a US judge blocked it from adding President Donald Trump's name...

​Abbott to Pay $385M Over Baby Formula Recall

​Abbott to Pay $385M Over Baby Formula Recall

byEriki Joan Ugunushe
0

​Healthcare giant Abbott Laboratories has agreed to pay nearly $385 million to resolve civil claims stemming from the Abbott baby formula recall settlement. The deal resolves a civil...

Six Nigerians Extradited to the US Over $6M Romance Scam

Six Nigerians Extradited to the US Over $6M Romance Scam

bySomto Nwanolue
0

Six Nigerian nationals linked to an organized criminal network that allegedly swindled American women out of over $6 million through online romance scams were extradited to the United...

Two Juveniles In Waymo Arrested After Police Discover ‘Ghost Gun’

Two Juveniles In Waymo Arrested After Police Discover ‘Ghost Gun’

byAyobami Owolabi
0

Two young passengers travelling in an autonomous vehicle were arrested in San Francisco after police allegedly discovered an illegal “ghost gun” inside the car. The San Francisco Police...

Next Post
Russian Bomb Kills Civilians in Kharkiv: A Brutal Attack on Ukraine

Russian Bomb Kills Civilians in Kharkiv: A Brutal Attack on Ukraine

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Federal Character

We bring to you precise and factual news.
Towson, Baltimore, Maryland, USA

Recent Posts

  • Chris Brown Thanks Jasmine Crockett for Honor, Apologizes for Backlash
  • US Extends Visa Ban on Abbas, Barring Him from UN General Assembly
  • US Measles Deaths Rise as Local Officials Fill RFK Jr’s Vaccine Void

Categories

  • Beauty
  • Business & Finance
  • Entertainment
  • Fashion & Lifestyle
  • Food & Nutrition
  • Government
  • Health
  • News
  • Politics
  • Sports
  • Tech

Weekly Newsletter

  • Home
  • About Federal Character
  • Advertise With Us
  • Cookie Policy
  • Sitemap

Copyright © FederalCharacter.com 2026 .

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • News
  • Government
  • Business & Finance
  • Entertainment
  • Sports
  • Tech
  • Health
  • About Federal Character
  • Advertise With Us

Copyright © FederalCharacter.com 2026 .